[1] Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer, 2012, 12(4): 278-287.[2] Weiner LM, Murray JC, Shuptrine CW. Antibody-based immunotherapy of cancer. Cell, 2012, 148(6): 1081-1084.[3] Ordás I, Mould DR, Feagan BG, Sandborn WJ. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther, 2012, 91(4): 635 -646.[4] Chugh PK. Lupus: novel therapies in clinical development. Eur J Intern Med, 2012, 23 (3): 212-218.[5] Wurch T, Lowe P, Caussanel V, Bes C, Beck A, Corvaia N. Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on dis-covery research and clinical validation. Curr Pharm Biotechno, 2008, 9(6): 502-509.[6] Skerra A. Alternative non-antibody scaffolds for molecular recognition. Curr Opin Biotech, 2007, 18(4): 295-304.[7] Pancer Z, Amemiya CT, Ehrhardt GRA, Ceitlin J, Gartland GL, Cooper MD. Somatic diversification of variable lym-phocyte receptors in the agnathan sea lamprey. Nature, 2004, 430(6996): 174- 180.[8] Alder MN, Herrin BR, Sadlonova A, Stockard CR, Grizzle WE, Gartland LA, Gartland GL, Boydston JA, Turnbough CL Jr, Cooper MD. Antibody responses of variable lym-phocyte receptors in the lamprey. Nat Immunol, 2008, 9(3): 319-327.[9] Herrin BR, Alder MN, Roux KH, Sina C, Ehrhardt GR, Boydston JA, Turnbough CL Jr, Cooper MD. Structure and specificity of lamprey monoclonal antibodies. Proc Natl Acad Sci USA, 2008, 105 (6): 2040-2045.[10] Pancer Z, Saha NR, Kasamatsu J, Suzuki T, Amemiya CT, Kasahara M, Cooper MD. Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci USA, 2005, 102(26): 9224-9229.[11] Kasamatsu J, Sutoh Y, Fugo K, Otsuka N, Iwabuchi K, Kasahara M. Identification of a third variable lymphocyte receptor in the lamprey. Proc Natl Acad Sci USA, 2010, 107(32): 14304- 14308.[12] Rogozin IB, Iyer LM, Liang L, Glazko GV, Liston VG, Pavlov YI, Aravind L, Pancer Z. Evolution and diversifi-cation of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase. Nat Immunol, 2007, 8(6): 647-656.[13] Nagawa F, Kishishita N, Shimizu K, Hirose S, Miyoshi M, Nezu J, Nishimura T, Nishizumi H, Takahashi Y, Hashimoto SI, Takeuchi M, Miyajima A, Takemori T, Otsuka AJ, Sakano H. Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice. Nat Immunol, 2007, 8(2): 206-213.[14] Alder MN, Rogozin IB, Iyer LM, Glazko GV, Cooper MD, Pancer Z. Diversity and function of adaptive immune receptors in a jawless vertebrate. Science, 2005, 310(5756): 1970-1973.[15] Han BW, Herrin BR, Cooper MD, Wilson IA. Antigen recognition by variable lymphocyte receptors. Science, 2008, 321(5897): 1834-1837.[16] Boehm T, McCurley N, Sutoh Y, Schorpp M, Kasahara M, Cooper MD. VLR-based adaptive immunity. Annu Rev Immunol, 2012, 30(1): 203-220.[17] Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet, 2010, 11(1): 47-59.[18] Kim HM, Oh SC, Lim KJ, Kasamatsu J, Heo JY, Park BS, Lee H, Yoo OJ, Kasahara M, Lee JO. Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem, 2007, 282(9): 6726-6732.[19] Velikovsky CA, Deng L, Tasumi S, Iyer LM, Kerzic MC, Aravind L, Pancer Z, Mariuzza RA. Structure of a lamprey variable lymphocyte receptor in complex with a protein antigen. Nat Struct Mol Biol, 2009, 16(7): 725-730.[20] Tasumi S, Velikovsky CA, Xu G, Gai SA, Wittrup KD, Flajnik MF, Mariuzza RA, Pancer Z. High- affinity lamprey VLRA and VLRB monoclonal antibodies. Proc Natl Acad Sci USA, 2009, 106(31): 12891-12896.[21] Deng L, Velikovsky CA, Xu G, Iyer LM, Tasumi S, Kerzic MC, Flajnik MF, Aravind L, Pancer Z, Mariuzza RA. A structural basis for antigen recognition by the T cell-like lymphocytes of sea lamprey. Proc Natl Acad Sci USA, 2010, 107(30): 13408-13413.[22] Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA, 1989, 86(15): 5938-5942.[23] Wezner-Ptasińska M, Krowarsch D, Otlewski J. Design and characteristics of a stable protein scaffold for specific binding based on variable lymphocyte receptor sequences. Biochim Biophys Acta, 2011, 1814(9): 1140-1145.[24] Chao GE, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc, 2006, 1(2): 755-768.[25] Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol, 2007, 17(4): 467-473.[26] Xu G, Tasumi S, Pancer Z. Yeast surface display of lamprey variable lymphocyte receptors. Methods Mol Biol, 2011, 748: 21-33.[27] Marks JD, Bradbury A. Selection of human antibodies from phage display libraries. Methods Mol Biol, 2004, 248: 161-176.[28] Lee SC, Park K, Han J, Lee JJ, Kim HJ, Hong S, Heu W, Kim YJ, Ha JS, Lee SG, Cheong HK, Jeon YH, Kim D, Kim HS. Design of a binding scaffold based on variable lymphocyte receptors of jawless vertebrates by module engi-neering. Proc Natl Acad Sci USA, 2012, 109(9): 3299-3304.[29] Nuttall SD, Wilkins ML, Streltsov VA, Pontes-Braz L, Dolezal O, Tran H, Liu CQ. Isolation, kinetic analysis, and structural characterization of an antibody targeting the Bacillus anthracis major spore surface protein BclA. Proteins, 2011, 79(4): 1306-1317.[30] Kirchdoerfer RN, Herrin BR, Han BW, Turnbough CL Jr, Cooper MD, Wilson IA. Variable lymphocyte receptor recognition of the immunodominant glycoprotein of Bacillus anthracis spores. Structure, 2012, 20(3): 479-486.[31] Sarkar S, Tang XL, Das D, Spencer JS, Lowary TL, Suresh MR. A bispecific antibody based assay shows po-tential for detecting tuberculosis in resource constrained laboratory settings. PLoS ONE, 2012, 7(2): e32340.[32] Kontermann R. Dual targeting strategies with bispecific antibodies. MAbs, 2012, 4(2): [Epub ahead of print]. (未出版刊物)[33] Yu CL, Ali S, St-Germain J, Liu YL, Yu XC, Jaye DL, Moran MF, Cooper MD, Ehrhardt GRA. Purification and identification of cell surface antigens using lamprey monoclonal antibodies. J Immunol Methods, 2012, 386(1-2): 43-49.[34] Hong X, Ma MZ, Gildersleeve JC, Chowdhury S, Barchi JJ Jr, Mariuzza RA, Murphy MB, Mao L, Pancer Z. Sugar-binding proteins from fish: selection of high affinity "Lambodies" that recognize biomedically relevant glycans. ACS Chem Biol, 2012, [Epub ahead of print]. (未出版刊物)[35] Gebauer M, Skerra A. Engineered protein scaffolds as next-generation antibody therapeutics. Curr Opin Chem Biol, 2009, 13(3): 245-255. |